Dr Hua Mu has joined WuXi PharmaTech as Senior Vice President of Operations and Global Head of the Product Development Service and Partnership Business Unit.
Mu has more than 18 years of clinical research and development experience, having held medical and clinical leadership positions with several global pharmaceutical and biotech companies, including Roche, Abraxis Bioscience (now Celgene), Biogen Idec, Genentech, and Procter and Gamble.
Before joining WuXi, Mu was Executive Vice President and Chief Medical Officer at Hutchison MediPharma, a company that in four years has successfully obtained five IND approvals and one Phase II/III CTA approval from the China Food and Drug Administration and advanced six compounds into various stages of clinical development.
WuXi PharmaTech is a pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the US.
